Abstract.
Protein 4.1 is an important structural protein that is expressed in erythroid and in a variety of nonerythroid tissues. In mammalian erythrocytes, it plays a key role in regulating the physical properties of mechanical stability and deformability in membranes by stabilizing the spectrin–actin interaction. The protein 4.1 family mainly comprises 4.1R, 4.1G (general type), 4.1B (brain type), and 4.1N (neuron type). We identified a novel human 4.1 (4.1O) gene that is 2312 bp in length and encodes a protein of 553 amino acid residues. The protein shared homology with mouse protein 4.1B (identity 38%, similarity 55%) with a FERM domain. The expression pattern of the human 4.1O gene in 16 tissues showed that there was a transcript only in ovary, whereas in the remaining 15 tissues, specific bands of the transcript could not be detected. In eight human fetal tissues, the specific bands of the transcript could be detected in skeletal muscle, with lower levels detected in thymus and brain. The 4.1O gene consists of 14 exons and 13 introns and was mapped to Chromosome 9q21–9q22 by bioinformatics analysis.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: October 1, 2002 / Accepted: November 11, 2002
Acknowledgments This research was funded by a grant from the Natural Science Foundation of China (30170345).
The first two authors contributed equally to this work.
Correspondence to:Y. Mao
Rights and permissions
About this article
Cite this article
Ni, X., Ji, C., Cao, G. et al. Molecular cloning and characterization of the protein 4.1O gene, a novel member of the protein 4.1 family with focal expression in ovary. J Hum Genet 48, 101–106 (2003). https://doi.org/10.1007/s100380300015
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380300015
This article is cited by
-
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
Breast Cancer (2022)
-
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT
International Journal of Clinical Oncology (2021)
-
rs1888747 polymorphism in the FRMD3 gene, gene and protein expression: role in diabetic kidney disease
Diabetology & Metabolic Syndrome (2016)
-
FRMD3 gene: its role in diabetic kidney disease. A narrative review
Diabetology & Metabolic Syndrome (2015)
-
Glomerular diseases: genetic causes and future therapeutics
Nature Reviews Nephrology (2010)